Principles of antibacterial dosing in continuous renal replacement therapy.
about
Treatment with echinocandins during continuous renal replacement therapyA Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKDβ-lactam antibiotic concentrations during continuous renal replacement therapy.Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?Using population pharmacokinetics to determine gentamicin dosing during extended daily diafiltration in critically ill patients with acute kidney injury.Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Colistin pharmacokinetics in burn patients during continuous venovenous hemofiltration.A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltrationPharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT.SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patientsDoes Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy.Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.Antibiotic dosing in critically ill patients with acute kidney injury.How to optimize drug delivery in renal replacement therapy.Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease.Continuous renal replacement therapy in neonates weighing less than 3 kg.Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: opportunities for pharmacists.Drug absorption, distribution, metabolism and excretion considerations in critically ill adults.Clinical implications of antibiotic pharmacokinetic principles in the critically ill.Compliance With Institutional Antimicrobial Dosing Guidelines in Patients Receiving Continuous Venovenous Hemodialysis.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".Pharmacokinetic considerations for drugs administered in the critically ill.Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injuryCaspofungin Population Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-Venous Haemofiltration or Haemodiafiltration.The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.[Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?][Antibiotic dosing for renal function disorders and continuous renal replacement therapy].Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative.Daptomycin serum levels in critical patients undergoing continuous renal replacement.Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial.Pharmacokinetic/pharmacodynamic parameters for treatment optimization of infection due to antibiotic resistant bacteria: a summary for practical purposes in children and adults.Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients.
P2860
Q27012864-221D451A-FA16-4020-B83F-59FBB3A62DDAQ28087621-3B320CAE-A0D9-491E-8EC3-F0C36AFCE9B1Q33821438-0FC0D815-180F-49BC-8897-A0FCA4F1E144Q33821554-92BA72D9-D0B8-407D-9585-474E69F1F6A3Q33821972-B1324C60-9313-4E1E-9B29-F0746E5EA590Q34108507-8C35131E-8674-44A4-9E31-2521EDC1BB48Q34274190-3EF00234-FDDB-4210-B8EA-7DD4B8E82A7AQ34894900-DEF0E34F-270D-4DD2-B2D3-65EA8A3C8D4BQ34922728-5117DF17-11BF-490C-BD1C-DD40ED22F4C7Q35504097-6C15EC4A-93DD-4B1E-92EE-920A8F646CF5Q35598414-0281A2A8-0769-42A4-9F26-41DA471C5835Q35598435-C1C3E7A2-52E1-4D8C-A2CF-54180E5AC3EEQ35827280-71FABC61-29C0-4EF9-BC68-3F261D9AEDC4Q35942407-5C10F4EC-C08A-4F0C-94F0-8ED7BA901048Q36287127-0454A55A-CFC2-44C1-B566-18A69C97DA86Q37036404-B78537DA-C3FE-4FC0-97A2-41470D04F7D9Q37119964-6D3EBA87-A5C3-4E85-9727-D802DD3F6AAEQ37643628-A224D35F-EAB0-4A0E-8C12-632C52752101Q37846092-A0BB9946-F180-423E-A0BB-19F08885B52DQ37868687-801E2D09-199F-4E4C-B441-7F84D42A27DAQ37957195-8139B8A4-AACC-4C6F-9544-B6DC4EEB1F1FQ37974645-41A35AEC-045D-4753-AB2F-26C966FE124BQ38043454-7C68C250-A191-4554-B336-71B9E0EB6543Q38072720-9F438B85-4FF6-4E8F-968C-3AD8568544BCQ38107537-AA7EB55B-9E4E-4AFC-A5DD-817FAF16E232Q38138835-D28D6C40-6C65-482B-A6FB-47D986734375Q38181340-6BD8002D-BC22-420A-861F-02D47936515BQ38261172-893311C7-D79B-475D-B310-6C2588B2BA57Q38351793-62E6BC1E-7B16-439F-BE19-5E1B7C94A707Q38365787-966F8933-443F-4D87-8360-6634981EB68AQ38382954-FB8E5AB8-C2C7-483C-8321-12FD9A4B98E8Q38837353-55D1B556-F008-4805-AF15-0E3AAC0E21D0Q40541397-1C30FBEA-523F-4D45-8D10-9C8CA70124A6Q41379961-1808D918-BC00-41F1-8773-79D95F0A5A70Q41819424-36E8EE66-1937-44F0-A315-F5CC2546394FQ42285206-A3C62919-363F-4C92-BD95-3162B4F151ADQ44311698-33920C86-D3D9-45F9-A011-A51ED25BD531Q46457513-16AFA7F9-2B4C-4DDC-9843-DD26FA164974Q48197188-7DDDEE7D-55EE-411C-9DDA-5A2CCF167D0CQ49894608-E4DC9A91-BC44-40CE-90DE-5E9C3F3E4A75
P2860
Principles of antibacterial dosing in continuous renal replacement therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Principles of antibacterial dosing in continuous renal replacement therapy.
@en
type
label
Principles of antibacterial dosing in continuous renal replacement therapy.
@en
prefLabel
Principles of antibacterial dosing in continuous renal replacement therapy.
@en
P2093
P50
P1476
Principles of antibacterial dosing in continuous renal replacement therapy.
@en
P2093
Gordon Choi
Ross Freebairn
P304
P356
10.1097/CCM.0B013E3181AAB3D0
P407
P577
2009-07-01T00:00:00Z